DEXELL® VUR Gel

Injectable implant for the treatment of vesicoureteral reflux (VUR)

What is DEXELL® VUR?

After injection into the submucosa of the ureteral orifice, DEXELL® VUR forms a bulking mass that prevents reflux. The dextranomer microparticles stimulate collagen production and fibroblast growth, leading to long-lasting tissue reinforcement at the injection site.

Description
How to use

The gel is endoscopically injected through a cystoscope, directly beneath the mucosa surrounding the ureteral orifice. Several injection techniques are available, such as STING (Subureteral Transurethral Injection) and HIT (Hydrodistention Implantation Technique), depending on the physician’s preference and the specific clinical situation.

Advantages DEXELL® VUR
  • Minimally Invasive Treatment:
    Endoscopic injection without the need for open surgery.
  • Biocompatible and Biodegradable:
    Made from materials that are safely absorbed by the body.
  • Promotes Tissue Growth:
    Positively charged microparticles enhance collagen production and fibroblast activity.
  • High Success Rates:
    Clinical studies show that DEXELL® VUR is effective in correcting VUR with minimal complications.
  • Fast Recovery Time:
    Patients can often go home the same day without the need for a urinary catheter.